Literature DB >> 2663075

Purification and characterization of lipoprotein lipase and hepatic triglyceride lipase from human postheparin plasma: production of monospecific antibody to the individual lipase.

Y Ikeda1, A Takagi, A Yamamoto.   

Abstract

Lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) were purified to homogeneity from human postheparin plasma. Molecular, catalytic and immunological properties of the purified enzymes were investigated. The native molecular weights of LPL and HTGL were 67,200 and 65,500, respectively, by gel chromatography. The subunit molecular weights of LPL and HTGL were 60,600 and 64,600, respectively, suggesting that these enzymes are catalytically active in a monomeric form. In addition, the purified LPL and HTGL each gave a single protein band when they were detected as glycoproteins with a probe of concanavalin A. The purified enzyme preparations were free of detectable antithrombin III by Western blot analysis. Catalytic properties of the purified enzymes were examined using triolein-gum arabic emulsion and triolein particles stabilized with phospholipid monolayer as substrates. LPL catalyzed the complete hydrolysis of triolein to free oleate and monooleate in the presence of apolipoprotein C-II. Apparent Km values for triolein and apolipoprotein C-II were 1.0 mM and 0.6 microM, and Vmax was 40.7 mmol/h per mg. HTGL hydrolyzed triolein substrate at a rate much slower than LPL, and produced mainly free oleate with little monooleate. Apparent Km and Vmax values were 2.5 mM and 16.1 mmol/h per mg, respectively. Polyclonal antibodies were developed against the purified LPL and HTGL. The purity and specificity of these antisera were ascertained by immunotitration, Ouchterlony double diffusion and Western blot analyses. The anti-human LPL and anti-human HTGL antiserum specifically reacted with the corresponding either native or denaturated enzyme, indicating that two enzymes were immunologically distinct. We developed an assay system for LPL and HTGL in human PHP by selective immunoprecipitation of each enzyme with the corresponding antiserum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663075     DOI: 10.1016/0005-2760(89)90231-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Glycosylation, activity and secretion of lipoprotein lipase in cultured brown adipocytes of newborn mice. Effect of tunicamycin, monensin, 1-deoxymannojirimycin and swainsonine.

Authors:  H Masuno; C J Schultz; J W Park; E J Blanchette-Mackie; C Mateo; R O Scow
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

2.  A novel method of identifying genetic mutations using an electrochemical DNA array.

Authors:  Junko Wakai; Atsuko Takagi; Masato Nakayama; Takahito Miya; Takatoshi Miyahara; Tsuyoshi Iwanaga; Shigeori Takenaka; Yasuyuki Ikeda; Masahiko Amano; Tomohiro Urata
Journal:  Nucleic Acids Res       Date:  2004-10-21       Impact factor: 16.971

3.  Functional molecular mass of rat hepatic lipase in liver, adrenal gland and ovary is different.

Authors:  K Schoonderwoerd; M L Hom; L H Luthjens; D Vieira van Bruggen; H Jansen
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

4.  Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.

Authors:  D E Wilson; A Hata; L K Kwong; A Lingam; J Shuhua; D N Ridinger; C Yeager; K C Kaltenborn; P H Iverius; J M Lalouel
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma.

Authors:  S Imamura; J Kobayashi; K Nakajima; S Sakasegawa; A Nohara; T Noguchi; M A Kawashiri; A Inazu; S S Deeb; H Mabuchi; J D Brunzell
Journal:  J Lipid Res       Date:  2008-03-14       Impact factor: 5.922

6.  Lipoprotein lipase activity and its relationship to high milk fat transfer during lactation in grey seals.

Authors:  S J Iverson; M Hamosh; W D Bowen
Journal:  J Comp Physiol B       Date:  1995       Impact factor: 2.200

7.  Molecular studies on primary lipoprotein lipase (LPL) deficiency. One base deletion (G916) in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript.

Authors:  A Takagi; Y Ikeda; Z Tsutsumi; T Shoji; A Yamamoto
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

8.  Increased serum triglyceride clearance and elevated high-density lipoprotein 2 and 3 cholesterol during treatment of primary hypertriglyceridemia with bezafibrate.

Authors:  Nagahiko Sakuma; Reiko Ikeuchi; Takeshi Hibino; Takayuki Yoshida; Seiji Mukai; Sachie Akita; Kazuhiro Yajima; Hiromichi Miyabe; Toshihiko Goto; Norio Takada; Nobuyuki Ohte; Mitoshi Kunimatu; Genjiro Kimura
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

9.  Heparin-enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery.

Authors:  H Nakamura; D K Kim; D M Philbin; M B Peterson; F Debros; G Koski; J V Bonventre
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.